Romanian Society of Pharmaceutical Sciences

« Back to Farmacia Journal 6/2015

A HIGH-THROUGHPUT HPLC ASSAY FOR LEVOSIMENDAN IN HUMAN PLASMA WITH ESI-MS/MS DETECTION

LAURIAN VLASE1, BÉLA KISS2*, CORINA BOCSAN3, SANDA NEGRUTIU4, IOAN HOREA VLAD4, ANCA BUZOIANU3

1.Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, “Iuliu Haţieganu” University of Medicine and Pharmacy, no. 8 Victor Babeş, RO-400012, Cluj-Napoca, Romania
2.Department of Toxicology, Faculty of Pharmacy, “Iuliu Haţieganu” University of Medicine and Pharmacy, no. 6 Pasteur, RO-400023, Cluj-Napoca, Romania
3.Department of Pharmacology, Faculty of Medicine, “Iuliu Haţieganu” University of Medicine and Pharmacy, no. 8 Victor Babeş, RO-400012, Cluj-Napoca, Romania
4.Cardiovascular Surgical Clinic, “Nicolae Stancioiu” Heart Institute, Cluj-Napoca Romania

Download Full Article PDF

A new rapid, sensitive and selective liquid chromatography method coupled with ESI-MS/MS detection was developed and validated for the quantification of levosimendan in human plasma. As a part of the optimization process, two ion sources (electrospray ionization – ESI, and atmospheric pressure chemical ionization – APCI) were tested, in both, negative and positive ion mode and with different mobile phases for the chromatographic separation. The final assay consisted in a separation performed on a Zorbax SB-C18 column (100 mm x 3.0 mm i.d., 3 μm) with isocratic elution using a 66/34 (% v/v) mixture of 0.1% acetic acid /acetonitrile as mobile phase, followed by a gradient washing step. The MS/MS detection was performed by using ESI in negative ion mode and with m/z = 279.1→227.1 as the final transition monitored. The assay presents several advantages, such as the small sample volume (200 μL), simple and rapid sample processing technique (protein precipitation), high sensitivity and a very good selectivity guaranteed by the MS/MS detection. The method was successfully applied to a pharmacokinetic study in human subjects after an infusion of L-SIM.